Synaptic protein CSF levels relate to memory scores in individuals without dementia

Synaptic protein CSF levels relate to memory scores in individuals without dementia

Background: We investigated how cerebrospinal fluid levels of synaptic proteins associate with memory function in normal cognition (CN) and mild cognitive impairment (MCI), and investigated the effect of amyloid positivity on these associations. Methods: We included 242 CN (105(43%) abnormal amyloid...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Wesenhagen, KEJ, de Leeuw, DM, Tomassen, J, Gobom, J, Bos, I, Vos, SJB, Martinez-Lage, P, Tainta, M, Popp, J, Peyratout, G, Tsolaki, M, Vandenberghe, R, Freund-Levi, Y, Verhey, F, Lovestone, S, Streffer, J, Dobricic, V, Blennow, K, Scheltens, P, Smit, AB, Bertram, L, Teunissen, CE, Zetterberg, H, Tijms, BM
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	BioMed Central 2025

Ижил төстэй зүйлс

Synaptic protein CSF levels relate to memory scores in individuals without dementia
-н: Kirsten E. J. Wesenhagen, зэрэг
Хэвлэсэн: (2025-03-01)

CSF Proteomic Alzheimer’s Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
-н: Betty Marije Tijms, зэрэг
Хэвлэсэн: (2021-08-01)

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
-н: Elles Konijnenberg, зэрэг
Хэвлэсэн: (2020-05-01)

Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies
-н: Delvenne, A, зэрэг
Хэвлэсэн: (2024)

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
-н: Delvenne, A, зэрэг
Хэвлэсэн: (2024)

Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies
-н: Aurore Delvenne, зэрэг
Хэвлэсэн: (2024-07-01)

Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
-н: Pieter Jelle Visser, зэрэг
Хэвлэсэн: (2022-05-01)

Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
-н: Pieter Jelle Visser, зэрэг
Хэвлэсэн: (2022-03-01)

Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort
-н: Westwood, S, зэрэг
Хэвлэсэн: (2020)

Inflammatory biomarkers in Alzheimer's disease plasma
-н: Morgan, A, зэрэг
Хэвлэсэн: (2019)

MRI predictors of amyloid pathology: results from the EMIF-AD multimodal biomarker discovery study
-н: ten Kate, M, зэрэг
Хэвлэсэн: (2018)

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
-н: Shi, L, зэрэг
Хэвлэсэн: (2019)

Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset
-н: Jan Homann, зэрэг
Хэвлэсэн: (2022-03-01)

Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
-н: Alexander Neumann, зэрэг
Хэвлэсэн: (2023-10-01)

Sex-Specific Metabolic Pathways Were Associated with Alzheimer’s Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort
-н: Jin Xu, зэрэг
Хэвлэсэн: (2021-11-01)

P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles
-н: Kirsten E. J. Wesenhagen, зэрэг
Хэвлэсэн: (2022-07-01)

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
-н: Claudia Cicognola, зэрэг
Хэвлэсэн: (2021-02-01)

The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics
-н: Isabelle Bos, зэрэг
Хэвлэсэн: (2018-07-01)

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
-н: Bos, I, зэрэг
Хэвлэсэн: (2019)

Four subgroups based on tau levels in Alzheimer’s disease observed in two independent cohorts
-н: Flora H. Duits, зэрэг
Хэвлэсэн: (2021-01-01)

Plasma Proteomic Biomarkers Relating to Alzheimer’s Disease: A Meta-Analysis Based on Our Own Studies
-н: Liu Shi, зэрэг
Хэвлэсэн: (2021-07-01)

Harmonization and standardization of biofluid‐based biomarker measurements for AT(N) classification in Alzheimer's disease
-н: Chiara Giangrande, зэрэг
Хэвлэсэн: (2023-07-01)

Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.
-н: Mikko Hölttä, зэрэг
Хэвлэсэн: (2012-01-01)

Abnormal cerebrospinal fluid levels of amyloid and tau are associated with cognitive decline over time in cognitively normal older adults: A monozygotic twin study
-н: Jori Tomassen, зэрэг
Хэвлэсэн: (2022-01-01)

Predicting AT(N) pathologies in Alzheimer’s disease from blood-based proteomic data using neural networks
-н: Yuting Zhang, зэрэг
Хэвлэсэн: (2022-11-01)

Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: A systematic review and meta-analysis
-н: Bridel, C, зэрэг
Хэвлэсэн: (2019)

Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers
-н: Elena Camporesi, зэрэг
Хэвлэсэн: (2021-02-01)

CSF proteomic signature predicts progression to Alzheimer's disease dementia
-н: Eleonora M. Vromen, зэрэг
Хэвлэсэн: (2022-01-01)

Levels of ADAM10 are reduced in Alzheimer’s disease CSF
-н: Aitana Sogorb-Esteve, зэрэг
Хэвлэсэн: (2018-07-01)

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
-н: Johanna Nilsson, зэрэг
Хэвлэсэн: (2021-01-01)

Spitting image: can saliva biomarkers reflect Alzheimer's disease?
-н: Nicholas J. Ashton, зэрэг
Хэвлэсэн: (2021-06-01)

Editorial: Blood Biomarkers of Neurodegenerative Diseases
-н: Thomas K. Karikari, зэрэг
Хэвлэсэн: (2022-06-01)

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment
-н: Mara ten Kate, зэрэг
Хэвлэсэн: (2017-09-01)

Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
-н: Eline A. J. Willemse, зэрэг
Хэвлэсэн: (2021-01-01)

Corrigendum to “Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer’s disease” [Clin. Mass Spectrom. 14 (Part B) (2019) 74–82]
-н: Karl Hansson, зэрэг
Хэвлэсэн: (2022-11-01)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
-н: Henrik Zetterberg, зэрэг
Хэвлэсэн: (2021-02-01)

Changes in Adiposity and Cerebrospinal Fluid Biomarkers Following a Modified Mediterranean Ketogenic Diet in Older Adults at Risk for Alzheimer’s Disease
-н: Tina E. Brinkley, зэрэг
Хэвлэсэн: (2022-06-01)

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease
-н: Rosha Babapour Mofrad, зэрэг
Хэвлэсэн: (2019-12-01)

Early diagnosis of silent coronary artery disease in diabetic subjects - are intense efforts worth while?
-н: KEJ Airaksinen
Хэвлэсэн: (2001-07-01)

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
-н: Nicholas J. Ashton, зэрэг
Хэвлэсэн: (2019-12-01)